Seelos Therapeutics, Inc.: cashflow_financing

Value{"amount": 112067000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2021-01-01 – 2021-12-31
Statuscurrent
EntitySeelos Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001136261-22-000156 · Open the official SEC filing →
Retrieved: 2026-08-19T09:53:15.866234+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001017491/cashflow-financing/2021-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4d41f6b2-0889-4857-bdf5-505f2b925582

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies